Dual Effects of a RETN Single Nucleotide Polymorphism (SNP) at –420 on Plasma Resistin: Genotype and DNA Methylation

Methylation at RETN SNP–420 was inversely associated with plasma resistin dependent and independent of SNP–420 genotypes in the general Japanese population.AbstractContext:We previously reported that single nucleotide polymorphism (SNP)–420 C>G (rs1862513) in the promoter region of RETN was assoc...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism Vol. 102; no. 3; pp. 884 - 892
Main Authors: Onuma, Hiroshi, Tabara, Yasuharu, Kawamura, Ryoichi, Ohashi, Jun, Nishida, Wataru, Takata, Yasunori, Ochi, Masaaki, Nishimiya, Tatsuya, Ohyagi, Yasumasa, Kawamoto, Ryuichi, Kohara, Katsuhiko, Miki, Tetsuro, Osawa, Haruhiko
Format: Journal Article
Language:English
Published: Washington, DC Endocrine Society 01.03.2017
Copyright Oxford University Press
Oxford University Press
Subjects:
ISSN:0021-972X, 1945-7197
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Methylation at RETN SNP–420 was inversely associated with plasma resistin dependent and independent of SNP–420 genotypes in the general Japanese population.AbstractContext:We previously reported that single nucleotide polymorphism (SNP)–420 C>G (rs1862513) in the promoter region of RETN was associated with type 2 diabetes. Plasma resistin was tightly correlated with SNP–420 genotypes. SNP–420 is a CpG-SNP affecting the sequence of cytosine–phosphate–guanine dinucleotides.Objective:To examine whether methylation at SNP–420 affects plasma resistin, we analyzed plasma resistin and methylation at RETN SNP–420.Design and Methods:Genomic DNA was extracted from peripheral white blood cells in 2078 Japanese subjects. Quantification of the methylation was performed by pyrosequencing after DNA bisulfite conversion.Results:Methylation at SNP–420 was highest in the C/C genotype (36.9 ± 5.7%), followed by C/G (21.4 ± 3.5%) and G/G (2.9 ± 1.4%; P < 0.001). When assessed in each genotype, methylation at SNP–420 was inversely associated with plasma resistin in the C/C (β = –0.134, P < 0.001) or C/G (β = –0.227, P < 0.001) genotype. In THP-1 human monocytes intrinsically having the C/C genotype, a demethylating reagent, 5-aza-dC, decreased the methylation at SNP–420 and increased RETN messenger RNA. SNP+1263 (rs3745369), located in the 3′ untranslated region of RETN, was also associated with methylation at SNP–420. In addition, highly sensitive C-reactive protein was inversely associated with methylation at SNP–420 in the C/C genotype, whereas body mass index was positively associated.Conclusions:Plasma resistin was inversely associated with the extent of methylation at SNP–420 mainly dependent on the SNP–420 genotype. The association can also be explained partially independent of SNP–420 genotypes. SNP–420 could have dual, genetic and epigenetic effects on plasma resistin.
AbstractList Context:We previously reported that single nucleotide polymorphism (SNP)–420 C>G (rs1862513) in the promoter region of RETN was associated with type 2 diabetes. Plasma resistin was tightly correlated with SNP–420 genotypes. SNP–420 is a CpG-SNP affecting the sequence of cytosine–phosphate–guanine dinucleotides.Objective:To examine whether methylation at SNP–420 affects plasma resistin, we analyzed plasma resistin and methylation at RETN SNP–420.Design and Methods:Genomic DNA was extracted from peripheral white blood cells in 2078 Japanese subjects. Quantification of the methylation was performed by pyrosequencing after DNA bisulfite conversion.Results:Methylation at SNP–420 was highest in the C/C genotype (36.9 ± 5.7%), followed by C/G (21.4 ± 3.5%) and G/G (2.9 ± 1.4%; P < 0.001). When assessed in each genotype, methylation at SNP–420 was inversely associated with plasma resistin in the C/C (β = –0.134, P < 0.001) or C/G (β = –0.227, P < 0.001) genotype. In THP-1 human monocytes intrinsically having the C/C genotype, a demethylating reagent, 5-aza-dC, decreased the methylation at SNP–420 and increased RETN messenger RNA. SNP+1263 (rs3745369), located in the 3′ untranslated region of RETN, was also associated with methylation at SNP–420. In addition, highly sensitive C-reactive protein was inversely associated with methylation at SNP–420 in the C/C genotype, whereas body mass index was positively associated.Conclusions:Plasma resistin was inversely associated with the extent of methylation at SNP–420 mainly dependent on the SNP–420 genotype. The association can also be explained partially independent of SNP–420 genotypes. SNP–420 could have dual, genetic and epigenetic effects on plasma resistin.
CONTEXTWe previously reported that single nucleotide polymorphism (SNP)-420 C>G (rs1862513) in the promoter region of RETN was associated with type 2 diabetes. Plasma resistin was tightly correlated with SNP-420 genotypes. SNP-420 is a CpG-SNP affecting the sequence of cytosine-phosphate-guanine dinucleotides.OBJECTIVETo examine whether methylation at SNP-420 affects plasma resistin, we analyzed plasma resistin and methylation at RETN SNP-420.DESIGN AND METHODSGenomic DNA was extracted from peripheral white blood cells in 2078 Japanese subjects. Quantification of the methylation was performed by pyrosequencing after DNA bisulfite conversion.RESULTSMethylation at SNP-420 was highest in the C/C genotype (36.9 ± 5.7%), followed by C/G (21.4 ± 3.5%) and G/G (2.9 ± 1.4%; P < 0.001). When assessed in each genotype, methylation at SNP-420 was inversely associated with plasma resistin in the C/C (β = -0.134, P < 0.001) or C/G (β = -0.227, P < 0.001) genotype. In THP-1 human monocytes intrinsically having the C/C genotype, a demethylating reagent, 5-aza-dC, decreased the methylation at SNP-420 and increased RETN messenger RNA. SNP+1263 (rs3745369), located in the 3' untranslated region of RETN, was also associated with methylation at SNP-420. In addition, highly sensitive C-reactive protein was inversely associated with methylation at SNP-420 in the C/C genotype, whereas body mass index was positively associated.CONCLUSIONSPlasma resistin was inversely associated with the extent of methylation at SNP-420 mainly dependent on the SNP-420 genotype. The association can also be explained partially independent of SNP-420 genotypes. SNP-420 could have dual, genetic and epigenetic effects on plasma resistin.
Methylation at RETN SNP–420 was inversely associated with plasma resistin dependent and independent of SNP–420 genotypes in the general Japanese population.AbstractContext:We previously reported that single nucleotide polymorphism (SNP)–420 C>G (rs1862513) in the promoter region of RETN was associated with type 2 diabetes. Plasma resistin was tightly correlated with SNP–420 genotypes. SNP–420 is a CpG-SNP affecting the sequence of cytosine–phosphate–guanine dinucleotides.Objective:To examine whether methylation at SNP–420 affects plasma resistin, we analyzed plasma resistin and methylation at RETN SNP–420.Design and Methods:Genomic DNA was extracted from peripheral white blood cells in 2078 Japanese subjects. Quantification of the methylation was performed by pyrosequencing after DNA bisulfite conversion.Results:Methylation at SNP–420 was highest in the C/C genotype (36.9 ± 5.7%), followed by C/G (21.4 ± 3.5%) and G/G (2.9 ± 1.4%; P < 0.001). When assessed in each genotype, methylation at SNP–420 was inversely associated with plasma resistin in the C/C (β = –0.134, P < 0.001) or C/G (β = –0.227, P < 0.001) genotype. In THP-1 human monocytes intrinsically having the C/C genotype, a demethylating reagent, 5-aza-dC, decreased the methylation at SNP–420 and increased RETN messenger RNA. SNP+1263 (rs3745369), located in the 3′ untranslated region of RETN, was also associated with methylation at SNP–420. In addition, highly sensitive C-reactive protein was inversely associated with methylation at SNP–420 in the C/C genotype, whereas body mass index was positively associated.Conclusions:Plasma resistin was inversely associated with the extent of methylation at SNP–420 mainly dependent on the SNP–420 genotype. The association can also be explained partially independent of SNP–420 genotypes. SNP–420 could have dual, genetic and epigenetic effects on plasma resistin.
Methylation at RETN SNP-420 was inversely associated with plasma resistin dependent and independent of SNP-420 genotypes in the general Japanese population. Abstract We previously reported that single nucleotide polymorphism (SNP)-420 C>G (rs1862513) in the promoter region of RETN was associated with type 2 diabetes. Plasma resistin was tightly correlated with SNP-420 genotypes. SNP-420 is a CpG-SNP affecting the sequence of cytosine-phosphate-guanine dinucleotides. To examine whether methylation at SNP-420 affects plasma resistin, we analyzed plasma resistin and methylation at RETN SNP-420. Genomic DNA was extracted from peripheral white blood cells in 2078 Japanese subjects. Quantification of the methylation was performed by pyrosequencing after DNA bisulfite conversion. Methylation at SNP-420 was highest in the C/C genotype (36.9 ± 5.7%), followed by C/G (21.4 ± 3.5%) and G/G (2.9 ± 1.4%; P < 0.001). When assessed in each genotype, methylation at SNP-420 was inversely associated with plasma resistin in the C/C (β = -0.134, P < 0.001) or C/G (β = -0.227, P < 0.001) genotype. In THP-1 human monocytes intrinsically having the C/C genotype, a demethylating reagent, 5-aza-dC, decreased the methylation at SNP-420 and increased RETN messenger RNA. SNP+1263 (rs3745369), located in the 3' untranslated region of RETN, was also associated with methylation at SNP-420. In addition, highly sensitive C-reactive protein was inversely associated with methylation at SNP-420 in the C/C genotype, whereas body mass index was positively associated. Plasma resistin was inversely associated with the extent of methylation at SNP-420 mainly dependent on the SNP-420 genotype. The association can also be explained partially independent of SNP-420 genotypes. SNP-420 could have dual, genetic and epigenetic effects on plasma resistin.
We previously reported that single nucleotide polymorphism (SNP)-420 C>G (rs1862513) in the promoter region of RETN was associated with type 2 diabetes. Plasma resistin was tightly correlated with SNP-420 genotypes. SNP-420 is a CpG-SNP affecting the sequence of cytosine-phosphate-guanine dinucleotides. To examine whether methylation at SNP-420 affects plasma resistin, we analyzed plasma resistin and methylation at RETN SNP-420. Genomic DNA was extracted from peripheral white blood cells in 2078 Japanese subjects. Quantification of the methylation was performed by pyrosequencing after DNA bisulfite conversion. Methylation at SNP-420 was highest in the C/C genotype (36.9 ± 5.7%), followed by C/G (21.4 ± 3.5%) and G/G (2.9 ± 1.4%; P < 0.001). When assessed in each genotype, methylation at SNP-420 was inversely associated with plasma resistin in the C/C (β = -0.134, P < 0.001) or C/G (β = -0.227, P < 0.001) genotype. In THP-1 human monocytes intrinsically having the C/C genotype, a demethylating reagent, 5-aza-dC, decreased the methylation at SNP-420 and increased RETN messenger RNA. SNP+1263 (rs3745369), located in the 3' untranslated region of RETN, was also associated with methylation at SNP-420. In addition, highly sensitive C-reactive protein was inversely associated with methylation at SNP-420 in the C/C genotype, whereas body mass index was positively associated. Plasma resistin was inversely associated with the extent of methylation at SNP-420 mainly dependent on the SNP-420 genotype. The association can also be explained partially independent of SNP-420 genotypes. SNP-420 could have dual, genetic and epigenetic effects on plasma resistin.
Author Kohara, Katsuhiko
Nishida, Wataru
Nishimiya, Tatsuya
Kawamoto, Ryuichi
Onuma, Hiroshi
Ohashi, Jun
Ochi, Masaaki
Tabara, Yasuharu
Takata, Yasunori
Miki, Tetsuro
Ohyagi, Yasumasa
Osawa, Haruhiko
Kawamura, Ryoichi
AuthorAffiliation 1Departments of Diabetes and Molecular Genetics, 2Geriatric Medicine, and 3Community Medicine, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan; 4Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan; and 5Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-8654, Japan
AuthorAffiliation_xml – name: 1Departments of Diabetes and Molecular Genetics, 2Geriatric Medicine, and 3Community Medicine, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan; 4Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan; and 5Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-8654, Japan
Author_xml – sequence: 1
  givenname: Hiroshi
  surname: Onuma
  fullname: Onuma, Hiroshi
  email: harosawa@m.ehime-u.ac.jp
  organization: 1Departments of Diabetes and Molecular Genetics
– sequence: 2
  givenname: Yasuharu
  surname: Tabara
  fullname: Tabara, Yasuharu
  organization: 4Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan; and
– sequence: 3
  givenname: Ryoichi
  surname: Kawamura
  fullname: Kawamura, Ryoichi
  organization: 1Departments of Diabetes and Molecular Genetics
– sequence: 4
  givenname: Jun
  surname: Ohashi
  fullname: Ohashi, Jun
  organization: 5Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-8654, Japan
– sequence: 5
  givenname: Wataru
  surname: Nishida
  fullname: Nishida, Wataru
  organization: 1Departments of Diabetes and Molecular Genetics
– sequence: 6
  givenname: Yasunori
  surname: Takata
  fullname: Takata, Yasunori
  organization: 1Departments of Diabetes and Molecular Genetics
– sequence: 7
  givenname: Masaaki
  surname: Ochi
  fullname: Ochi, Masaaki
  organization: 1Departments of Diabetes and Molecular Genetics
– sequence: 8
  givenname: Tatsuya
  surname: Nishimiya
  fullname: Nishimiya, Tatsuya
  organization: 1Departments of Diabetes and Molecular Genetics
– sequence: 9
  givenname: Yasumasa
  surname: Ohyagi
  fullname: Ohyagi, Yasumasa
  organization: 2Geriatric Medicine, and
– sequence: 10
  givenname: Ryuichi
  surname: Kawamoto
  fullname: Kawamoto, Ryuichi
  organization: 3Community Medicine, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan
– sequence: 11
  givenname: Katsuhiko
  surname: Kohara
  fullname: Kohara, Katsuhiko
  organization: 2Geriatric Medicine, and
– sequence: 12
  givenname: Tetsuro
  surname: Miki
  fullname: Miki, Tetsuro
  organization: 2Geriatric Medicine, and
– sequence: 13
  givenname: Haruhiko
  surname: Osawa
  fullname: Osawa, Haruhiko
  organization: 1Departments of Diabetes and Molecular Genetics
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27929711$$D View this record in MEDLINE/PubMed
BookMark eNp9kkFvFCEYhompsdvqzbMh8WBNnAoMDOCtaddqUteNrYk3wg7gzsrAODA2e_M_-A_9Jc5020uTyoVAnufjy_dyAPZCDBaA5xgdY4LR2019TBCuCkIxfwRmWFJWcCz5HpghRHAhOfm2Dw5S2iCEKWXlE7BPuCSSYzwDv84G7eHcOVvnBKODGn6ZXy3gZRO-ewsXQ-1tzI2xcBn9to19t25SC48uF8vXUGf49_cfShCMAS69Tu1o29Sk3IR38NyGmLedhToYeLY4gZ9sXm-9zk0MT8Fjp32yz273Q_D1_fzq9ENx8fn84-nJRVEzInjBMJeYMWMMYyuJjag1qsxKS4NKgUhpiHTI0cpVRlDhkEVcYEdNjZnTuCzLQ3C0q9v18edgU1Ztk2rrvQ42DklhQbmQnKEJfXkP3cShD2N3qsQVLUeIov9RZGxICCLZVOvFLTWsWmtU1zet7rfqbu4jQHZA3ceUeutU3eSbyeReN15hpKZw1aZWU7hqCneU3tyT7uo-gNMdfh19tn364Ydr26u11T6vFRoXrbgoRoGjcjwV09WkvdppcegeeuDms5X_AEnlvQo
CitedBy_id crossref_primary_10_1089_gtmb_2017_0212
crossref_primary_10_3390_ijms231911813
crossref_primary_10_1038_s41598_019_51592_0
crossref_primary_10_3390_nu14235092
crossref_primary_10_1007_s13167_019_00178_x
crossref_primary_10_20960_nh_04206
crossref_primary_10_1097_MD_0000000000009485
crossref_primary_10_1038_s41598_024_84142_4
crossref_primary_10_1038_s41398_018_0205_8
crossref_primary_10_3390_nu14091789
crossref_primary_10_1016_j_ygeno_2018_06_005
crossref_primary_10_1002_jcp_29887
crossref_primary_10_1016_j_cca_2020_11_010
Cites_doi 10.1111/j.1365-2796.2007.01787.x
10.1371/journal.pmed.0010045
10.1007/s00125-012-2815-7
10.1038/nature08514
10.2337/dc06-1936
10.1172/JCI30938
10.1186/gb-2011-12-1-r10
10.2337/dc08-1625
10.1111/j.1365-2265.2006.02710.x
10.1210/me.2012-1004
10.1111/j.1365-2265.2007.03154.x
10.1371/journal.pone.0009718
10.1016/j.ajhg.2010.02.005
10.2217/epi.12.45
10.1016/j.ajhg.2008.03.015
10.1086/424761
10.1016/j.bbrc.2005.07.122
10.1038/35053000
10.1007/s00125-010-1665-4
10.1111/j.1369-1600.2011.00323.x
10.1530/eje.1.02338
10.1093/bioinformatics/btl268
10.1038/nrg2341
10.1038/nrg3142
10.1016/S0140-6736(13)62674-4
10.2337/db11-1048
10.1016/S0006-291X(02)02841-3
10.1186/1741-7015-8-87
10.1016/j.jacc.2005.04.022
10.1038/ng.946
10.1371/journal.pone.0073480
10.2337/diacare.27.10.2450
10.1007/s00125-007-0916-5
10.1161/01.CIR.0000155620.10387.43
10.7326/0003-4819-149-5-200809020-00005
10.1016/j.jacc.2007.06.012
10.1038/nature05913
10.1101/gr.104695.109
10.1371/journal.pgen.1000952
ContentType Journal Article
Copyright Copyright © 2017 by the Endocrine Society 2017
Copyright © Oxford University Press 2015
Copyright © 2017 by the Endocrine Society
Copyright © 2017 Endocrine Society
Copyright_xml – notice: Copyright © 2017 by the Endocrine Society 2017
– notice: Copyright © Oxford University Press 2015
– notice: Copyright © 2017 by the Endocrine Society
– notice: Copyright © 2017 Endocrine Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7T5
7TM
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1210/jc.2016-2417
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE - Academic

ProQuest One Academic Middle East (New)
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage 892
ExternalDocumentID 27929711
10_1210_jc_2016_2417
00004678-201703000-00007
10.1210/jc.2016-2417
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
-~X
.55
.GJ
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
3O-
3V.
4.4
48X
53G
5GY
5RS
5YH
7X7
88E
8F7
8FI
8FJ
AABZA
AACZT
AAIMJ
AAJQQ
AAKAS
AAPGJ
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAYJJ
ABBLC
ABDFA
ABDPE
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABUWG
ABVGC
ABWST
ABXVV
ACFRR
ACGFO
ACGFS
ACPRK
ACUTJ
ACYHN
ACZBC
ADBBV
ADGKP
ADGZP
ADHKW
ADQBN
ADRTK
ADVEK
ADZCM
AELWJ
AEMDU
AENEX
AENZO
AERZD
AETBJ
AEWNT
AFCHL
AFFNX
AFFQV
AFFZL
AFGWE
AFKRA
AFOFC
AFRAH
AFXAL
AFYAG
AGINJ
AGKRT
AGMDO
AGQXC
AGUTN
AHMBA
AHMMS
AI.
AJEEA
ALMA_UNASSIGNED_HOLDINGS
APIBT
APJGH
AQDSO
AQKUS
ARIXL
ASPBG
ATGXG
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BENPR
BEYMZ
BPHCQ
BSWAC
BTRTY
BVXVI
C45
CCPQU
CDBKE
CS3
D-I
DAKXR
DIK
E3Z
EBS
EIHJH
EJD
EMOBN
ENERS
F5P
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
FYUFA
GAUVT
GJXCC
GX1
H13
HMCUK
HVGLF
HZ~
H~9
IAO
IHR
INH
ITC
J5H
KBUDW
KOP
KQ8
KSI
KSN
L7B
M1P
M5~
MBLQV
MHKGH
MJL
N4W
N9A
NLBLG
NOMLY
NOYVH
NVLIB
O9-
OAUYM
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
PQQKQ
PROAC
PSQYO
REU
ROX
ROZ
TEORI
TJX
TLC
TMA
TR2
TWZ
UKHRP
VH1
VVN
W8F
WHG
WOQ
X52
X7M
YBU
YFH
YHG
YOC
YSK
ZGI
ZXP
ZY1
~02
~H1
ABXZS
ACVCV
ADMTO
ADNBA
AEMQT
AEOTA
AGORE
AHGBF
AJBYB
AJDVS
ALXQX
AVNTJ
NU-
OBFPC
PHGZM
PHGZT
AAYXX
AEHZK
AFFHD
CITATION
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
7XB
8FK
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c5287-5179155ddd55b91d8ca06dba9d038023d29f0f46f6d848f0e0781f4dc15fa1333
IEDL.DBID 7X7
ISICitedReferencesCount 13
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00004678-201703000-00007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0021-972X
IngestDate Sun Nov 09 14:11:06 EST 2025
Tue Oct 07 07:23:25 EDT 2025
Tue Oct 07 06:41:50 EDT 2025
Wed Feb 19 02:26:15 EST 2025
Sat Nov 29 02:29:11 EST 2025
Tue Nov 18 22:06:35 EST 2025
Fri May 16 03:42:55 EDT 2025
Fri Feb 07 10:35:36 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Copyright © 2017 by the Endocrine Society
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5287-5179155ddd55b91d8ca06dba9d038023d29f0f46f6d848f0e0781f4dc15fa1333
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://academic.oup.com/jcem/article-pdf/102/3/884/10913269/jc.2016-2417.pdf
PMID 27929711
PQID 2023882953
PQPubID 2046206
PageCount 9
ParticipantIDs proquest_miscellaneous_1847897503
proquest_journals_3164375040
proquest_journals_2023882953
pubmed_primary_27929711
crossref_citationtrail_10_1210_jc_2016_2417
crossref_primary_10_1210_jc_2016_2417
wolterskluwer_health_00004678-201703000-00007
oup_primary_10_1210_jc_2016-2417
PublicationCentury 2000
PublicationDate 2017-March
PublicationDateYYYYMMDD 2017-03-01
PublicationDate_xml – month: 03
  year: 2017
  text: 2017-March
PublicationDecade 2010
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
– name: Washington
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2017
Publisher Endocrine Society
Copyright Oxford University Press
Oxford University Press
Publisher_xml – name: Endocrine Society
– name: Copyright Oxford University Press
– name: Oxford University Press
References Suzuki (2019041122165989700_B17) 2008; 9
Ohmori (2019041122165989700_B12) 2005; 46
Yang (2019041122165989700_B21) 2012; 26
Osawa (2019041122165989700_B7) 2010; 53
Feil (2019041122165989700_B30) 2012; 13
Hage (2019041122165989700_B34) 2007; 50
Bird (2019041122165989700_B19) 2007; 447
Shetty (2019041122165989700_B38) 2004; 27
Taqi (2019041122165989700_B26) 2011; 16
Tsai (2019041122165989700_B28) 2012; 4
Bell (2019041122165989700_B31) 2011; 12
Gibbs (2019041122165989700_B32) 2010; 6
Chen (2019041122165989700_B14) 2009; 32
Osawa (2019041122165989700_B5) 2005; 335
Solé (2019041122165989700_B25) 2006; 22
Norata (2019041122165989700_B10) 2007; 262
Osawa (2019041122165989700_B11) 2008; 69
Dayeh (2019041122165989700_B24) 2013; 56
Sun (2019041122165989700_B36) 2013; 8
Ling (2019041122165989700_B20) 2008; 51
Schwartz (2019041122165989700_B13) 2011; 22
Ridker (2019041122165989700_B35) 2008; 82
Patel (2019041122165989700_B2) 2003; 300
Heidemann (2019041122165989700_B15) 2008; 149
Dick (2019041122165989700_B40) 2014; 383
Lehrke (2019041122165989700_B37) 2004; 1
Zhang (2019041122165989700_B33) 2010; 86
Onuma (2019041122165989700_B6) 2010; 5
Reilly (2019041122165989700_B8) 2005; 111
Wang (2019041122165989700_B39) 2010; 8
Zhao (2019041122165989700_B22) 2012; 61
Lienert (2019041122165989700_B29) 2011; 43
Osawa (2019041122165989700_B4) 2007; 30
Ling (2019041122165989700_B27) 2007; 117
Xu (2019041122165989700_B16) 2007; 66
Norata (2019041122165989700_B9) 2007; 156
Shoemaker (2019041122165989700_B23) 2010; 20
Lister (2019041122165989700_B18) 2009; 462
Steppan (2019041122165989700_B1) 2001; 409
Osawa (2019041122165989700_B3) 2004; 75
References_xml – volume: 262
  start-page: 104
  issue: 1
  year: 2007
  ident: 2019041122165989700_B10
  article-title: Effect of the –420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2007.01787.x
– volume: 1
  start-page: e45
  issue: 2
  year: 2004
  ident: 2019041122165989700_B37
  article-title: An inflammatory cascade leading to hyperresistinemia in humans
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.0010045
– volume: 56
  start-page: 1036
  issue: 5
  year: 2013
  ident: 2019041122165989700_B24
  article-title: Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets
  publication-title: Diabetologia
  doi: 10.1007/s00125-012-2815-7
– volume: 462
  start-page: 315
  issue: 7271
  year: 2009
  ident: 2019041122165989700_B18
  article-title: Human DNA methylomes at base resolution show widespread epigenomic differences
  publication-title: Nature
  doi: 10.1038/nature08514
– volume: 30
  start-page: 1501
  issue: 6
  year: 2007
  ident: 2019041122165989700_B4
  article-title: Plasma resistin, associated with single nucleotide polymorphism –420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population
  publication-title: Diabetes Care
  doi: 10.2337/dc06-1936
– volume: 117
  start-page: 3427
  issue: 11
  year: 2007
  ident: 2019041122165989700_B27
  article-title: Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle
  publication-title: J Clin Invest
  doi: 10.1172/JCI30938
– volume: 12
  start-page: R10
  issue: 1
  year: 2011
  ident: 2019041122165989700_B31
  article-title: DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines
  publication-title: Genome Biol
  doi: 10.1186/gb-2011-12-1-r10
– volume: 32
  start-page: 329
  issue: 2
  year: 2009
  ident: 2019041122165989700_B14
  article-title: Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1625
– volume: 66
  start-page: 211
  issue: 2
  year: 2007
  ident: 2019041122165989700_B16
  article-title: Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2006.02710.x
– volume: 26
  start-page: 1203
  issue: 7
  year: 2012
  ident: 2019041122165989700_B21
  article-title: Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2012-1004
– volume: 69
  start-page: 74
  issue: 1
  year: 2008
  ident: 2019041122165989700_B11
  article-title: Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2007.03154.x
– volume: 5
  start-page: e9718
  issue: 3
  year: 2010
  ident: 2019041122165989700_B6
  article-title: A at single nucleotide polymorphism-358 is required for G at –420 to confer the highest plasma resistin in the general Japanese population
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0009718
– volume: 86
  start-page: 411
  issue: 3
  year: 2010
  ident: 2019041122165989700_B33
  article-title: Genetic control of individual differences in gene-specific methylation in human brain
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2010.02.005
– volume: 4
  start-page: 511
  issue: 5
  year: 2012
  ident: 2019041122165989700_B28
  article-title: Using epigenome-wide association scans of DNA methylation in age-related complex human traits
  publication-title: Epigenomics
  doi: 10.2217/epi.12.45
– volume: 82
  start-page: 1185
  issue: 5
  year: 2008
  ident: 2019041122165989700_B35
  article-title: Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women’s Genome Health Study
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2008.03.015
– volume: 75
  start-page: 678
  issue: 4
  year: 2004
  ident: 2019041122165989700_B3
  article-title: The G/G genotype of a resistin single-nucleotide polymorphism at –420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3
  publication-title: Am J Hum Genet
  doi: 10.1086/424761
– volume: 335
  start-page: 596
  issue: 2
  year: 2005
  ident: 2019041122165989700_B5
  article-title: Resistin SNP–420 determines its monocyte mRNA and serum levels inducing type 2 diabetes
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2005.07.122
– volume: 409
  start-page: 307
  issue: 6818
  year: 2001
  ident: 2019041122165989700_B1
  article-title: The hormone resistin links obesity to diabetes
  publication-title: Nature
  doi: 10.1038/35053000
– volume: 53
  start-page: 795
  issue: 4
  year: 2010
  ident: 2019041122165989700_B7
  article-title: Is rs34861192 or rs1862513 a more promising variant for determining plasma resistin in an aged Japanese population?
  publication-title: Diabetologia
  doi: 10.1007/s00125-010-1665-4
– volume: 16
  start-page: 499
  issue: 3
  year: 2011
  ident: 2019041122165989700_B26
  article-title: Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics
  publication-title: Addict Biol
  doi: 10.1111/j.1369-1600.2011.00323.x
– volume: 156
  start-page: 279
  issue: 2
  year: 2007
  ident: 2019041122165989700_B9
  article-title: Plasma resistin levels correlate with determinants of the metabolic syndrome
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje.1.02338
– volume: 22
  start-page: 1928
  issue: 15
  year: 2006
  ident: 2019041122165989700_B25
  article-title: SNPStats: a web tool for the analysis of association studies
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btl268
– volume: 9
  start-page: 465
  issue: 6
  year: 2008
  ident: 2019041122165989700_B17
  article-title: DNA methylation landscapes: provocative insights from epigenomics
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg2341
– volume: 13
  start-page: 97
  issue: 2
  year: 2012
  ident: 2019041122165989700_B30
  article-title: Epigenetics and the environment: emerging patterns and implications
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg3142
– volume: 383
  start-page: 1990
  issue: 9933
  year: 2014
  ident: 2019041122165989700_B40
  article-title: DNA methylation and body-mass index: a genome-wide analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)62674-4
– volume: 61
  start-page: 542
  issue: 2
  year: 2012
  ident: 2019041122165989700_B22
  article-title: Global DNA methylation is associated with insulin resistance: a monozygotic twin study
  publication-title: Diabetes
  doi: 10.2337/db11-1048
– volume: 300
  start-page: 472
  issue: 2
  year: 2003
  ident: 2019041122165989700_B2
  article-title: Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/S0006-291X(02)02841-3
– volume: 8
  start-page: 87
  year: 2010
  ident: 2019041122165989700_B39
  article-title: Obesity related methylation changes in DNA of peripheral blood leukocytes
  publication-title: BMC Med
  doi: 10.1186/1741-7015-8-87
– volume: 46
  start-page: 379
  issue: 2
  year: 2005
  ident: 2019041122165989700_B12
  article-title: Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2005.04.022
– volume: 43
  start-page: 1091
  issue: 11
  year: 2011
  ident: 2019041122165989700_B29
  article-title: Identification of genetic elements that autonomously determine DNA methylation states
  publication-title: Nat Genet
  doi: 10.1038/ng.946
– volume: 8
  start-page: e73480
  issue: 8
  year: 2013
  ident: 2019041122165989700_B36
  article-title: Gene-specific DNA methylation association with serum levels of C-reactive protein in African Americans
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0073480
– volume: 27
  start-page: 2450
  issue: 10
  year: 2004
  ident: 2019041122165989700_B38
  article-title: Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.10.2450
– volume: 51
  start-page: 615
  issue: 4
  year: 2008
  ident: 2019041122165989700_B20
  article-title: Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion
  publication-title: Diabetologia
  doi: 10.1007/s00125-007-0916-5
– volume: 111
  start-page: 932
  issue: 7
  year: 2005
  ident: 2019041122165989700_B8
  article-title: Resistin is an inflammatory marker of atherosclerosis in humans
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000155620.10387.43
– volume: 149
  start-page: 307
  issue: 5
  year: 2008
  ident: 2019041122165989700_B15
  article-title: Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-149-5-200809020-00005
– volume: 50
  start-page: 1115
  issue: 12
  year: 2007
  ident: 2019041122165989700_B34
  article-title: C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.06.012
– volume: 447
  start-page: 396
  issue: 7143
  year: 2007
  ident: 2019041122165989700_B19
  article-title: Perceptions of epigenetics
  publication-title: Nature
  doi: 10.1038/nature05913
– volume: 20
  start-page: 883
  issue: 7
  year: 2010
  ident: 2019041122165989700_B23
  article-title: Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome
  publication-title: Genome Res
  doi: 10.1101/gr.104695.109
– volume: 22
  start-page: 259
  issue: 7
  year: 2011
  ident: 2019041122165989700_B13
  article-title: Human resistin: found in translation from mouse to man
  publication-title: Trends Endocrinol Metab
– volume: 6
  start-page: e1000952
  issue: 5
  year: 2010
  ident: 2019041122165989700_B32
  article-title: Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1000952
SSID ssj0014453
Score 2.2953718
Snippet Methylation at RETN SNP–420 was inversely associated with plasma resistin dependent and independent of SNP–420 genotypes in the general Japanese...
We previously reported that single nucleotide polymorphism (SNP)-420 C>G (rs1862513) in the promoter region of RETN was associated with type 2 diabetes. Plasma...
Methylation at RETN SNP-420 was inversely associated with plasma resistin dependent and independent of SNP-420 genotypes in the general Japanese population....
Context:We previously reported that single nucleotide polymorphism (SNP)–420 C>G (rs1862513) in the promoter region of RETN was associated with type 2...
CONTEXTWe previously reported that single nucleotide polymorphism (SNP)-420 C>G (rs1862513) in the promoter region of RETN was associated with type 2 diabetes....
SourceID proquest
pubmed
crossref
wolterskluwer
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 884
SubjectTerms 3' Untranslated regions
Aged
Asians - genetics
Azacytidine
Bisulfite
Body Mass Index
C-reactive protein
C-Reactive Protein - metabolism
Cell Line
CpG Islands
Cytosine
Deoxyribonucleic acid
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - genetics
DNA
DNA Methylation
Epigenesis, Genetic - genetics
Epigenetics
Female
Gene polymorphism
Genotype
Genotype & phenotype
Genotypes
Guanine
Humans
Japan
Leukocytes
Male
Middle Aged
Monocytes
mRNA
Nucleotide sequence
Plasma
Polymorphism
Polymorphism, Single Nucleotide
Resistin - blood
Resistin - genetics
RNA, Messenger - metabolism
Single-nucleotide polymorphism
Title Dual Effects of a RETN Single Nucleotide Polymorphism (SNP) at –420 on Plasma Resistin: Genotype and DNA Methylation
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-201703000-00007
https://www.ncbi.nlm.nih.gov/pubmed/27929711
https://www.proquest.com/docview/2023882953
https://www.proquest.com/docview/3164375040
https://www.proquest.com/docview/1847897503
Volume 102
WOSCitedRecordID wos00004678-201703000-00007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1945-7197
  dateEnd: 20211231
  omitProxy: false
  ssIdentifier: ssj0014453
  issn: 0021-972X
  databaseCode: 7X7
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1945-7197
  dateEnd: 20211231
  omitProxy: false
  ssIdentifier: ssj0014453
  issn: 0021-972X
  databaseCode: BENPR
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELZgQwg08RtWGJORQGJClpLGieO9oME6eFkUbUPqm-XajtTRxmNJmfjvuUvcskqMF176Ykdydefz9_nO3xHyNuXaJI6D80pTMS64YXIiEpYZmwF3E0JK3TWbEEWRj8eyDBduTSirXMbELlBbb_COHEl6AmhQpsnHix8Mu0ZhdjW00LhNNrFtNmrni_GKcAFXCCqUWIYghuNQ-I6vVs5RvjDOGBxgYu1IWnvmdg1t3idbVx4T2M33rn792il09PB_1_-IPAj4kx70DvOY3HL1E3L3OGTYn5L2cAHDvaZxQ31FNT0ZnRX0FI64maMFyh_7dmodLf3s19yDmabNnL4_Lco9qlvK-DCivqYloPI5fOsaDCL1Pv3iao_3vVTXlh4WB_TYgY_0lXjPyLej0dnnryx0ZmAmBYrFUNcLgIi1Nk0nMra50VFmJ1raKEFFOTuUVVTxrMpszvMqcigpVHFr4rTSwIqT52Sj9rXbJtQAPpsAaAav0Nyha_AcSFuKSnsAPeMB-bA0jjJBthy7Z8wU0hcwpTo3Ck2p0JQD8m41-6KX67hhHgU73zSF9VN2loZUYV836o8V_zqcxJgHTSEwDsib1TBsWMzC6Nr5RaOAUotcYvp4QF70vrVaB6o5ShHDn2Zrzqb6R7GqY3QALyC2xRiqe1WASLz891pfkXv4QV86t0M22suFe03umJ_ttLnc7fZM95vvks1Po6I8-Q01RhiU
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtNAEB2VgrgIcb8ECiwSlajQSnZ8WS8SQhVpadXGimgq5W3r7K6llMQutUPVn-IbmfElNBLlrQ8879pa22dn5nhmzwC8C_xEe9ZH8Eqdcl_4msux8HioTYjcTQgpk6rZhIjjaDSSgxX41Z6FobLK1iZWhtrkmv6RE0n3MBqUgff55AenrlGUXW1baNSw2LPnZ0jZik-7Pfy-693u9tbwyw5vugpwHSA94KRJhU7UGBMEY-maSCdOaMaJNI5HamimK1Mn9cM0NJEfpY4lOZzUN9oN0gQZnYf3vQbX0Y4LKiETowXBQ27SqF5S2YPojppCezolc0xyiW7I0WGKJRe4dKzuQnR7B-6e5ZQwL75X9fIXvN72_f_tfT2Ae018zTbrDfEQVmz2CG72mwqCx1D25jhcazYXLE9Zwr5tDWN2gC58allM8s55OTGWDfLp-SxHGE6KGXt_EA82WFIy7ncdlmdsgKxjhtfagoxk9pF9tVlO_7NZkhnWizdZ3-IeqCsNn8DhlTzzU1jN8sw-B6Yx_hwjKUDUJ74l6PsRktKAlAQxtHY78KEFg9KNLDt1B5kqomcIHXWsFUFHEXQ6sL6YfVLLkVwyjyGuLpvC6ylrLXBUY7cK9Qc1fx32XMrzBmj4O_B2MYwGibJMSWbzeaFcjHciSenxDjyrsbxYB6lVSuHiQ_MlcKv60K-qGCuGT2i7XXJFteqBI178e61v4NbOsL-v9nfjvZdwmy6uywTXYLU8ndtXcEP_LCfF6etqvzI4umrA_wa_NXF5
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dual+Effects+of+a+RETN+Single+Nucleotide+Polymorphism+%28SNP%29+at+-420+on+Plasma+Resistin%3A+Genotype+and+DNA+Methylation&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Onuma%2C+Hiroshi&rft.au=Tabara%2C+Yasuharu&rft.au=Kawamura%2C+Ryoichi&rft.au=Ohashi%2C+Jun&rft.date=2017-03-01&rft.eissn=1945-7197&rft.volume=102&rft.issue=3&rft.spage=884&rft.epage=892&rft_id=info:doi/10.1210%2Fjc.2016-2417&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon